Maravai LifeSciences Holdings (MRVI) stock
MRVI's Quality Score rose 4 points on Fri, Oct 2, to 8. Its moving averages lined up in order (4 chart checks started). 1 more reason, for Pro members.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Why MRVI scores 11
Above AverageTrending up, 7 of 14 checks firingWhat the Quality Score means
Well above its own recent run. MRVI scores 11 today, against a median of 5 over its last 20 recorded sessions.
- +7Chart checks 7 of 14 firing right now, one point each
- +3Long-term trend above a rising 200-day average, near its 52-week high
- Run-up adds
- Cash flow subtracts
What's next
Expected to report Thu Nov 5, after the close
After its last 4 reports it closed +7.8% on average, higher 2 of 4 times.
What would move MRVI's score: 6 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
MRVI has 7 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1468.9
- MACD (12, 26, 9)Above signal
- 50-day average$7.11
- 200-day average$4.87
- ADX 1420.4
- Support$6.49
- Resistance$9.42
- Volume1.1x
How MRVI ranks in Pharma
MRVI is #7 of 91 by Quality Score. The top three are shown with their scores, and more by name.
ABBV10/1421
GMAB8/1417
CRON3/1413
MNKDOpen for its score
MRKOpen for its score
MYGNOpen for its score
NEOGOpen for its score
MRVI7/1411
When does MRVI report earnings, and what happens after?
Expected to report Thu Nov 5, after the close (in 31 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 6, 2026After close | After close | -10.4% | -0.3% | -7.5% |
| May 7, 2026After close | After close | +11.4% | +23.1% | +8.9% |
| Feb 25, 2026After close | After close | +9.8% | +9.2% | +17.2% |
| Nov 6, 2025After close | After close | -11.9% | -0.7% | +12.5% |
About Maravai LifeSciences Holdings
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of MRVI's score, with the points and the reason
- All 14 checks on MRVI and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on MRVI
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.